Compounds > bis(2,4,5-trichloro-6-carbopentoxyphenyl)oxalate
Page last updated: 2024-11-06

bis(2,4,5-trichloro-6-carbopentoxyphenyl)oxalate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID93137
SCHEMBL ID79416
MeSH IDM0121829

Synonyms (41)

Synonym
AKOS015837625
bis-[2,4,5-trichloro-6-(penthyloxycarbonyl)phenyl]oxalate
oxalic acid bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] ester
oxalic acid bis[2,4,5-trichloro-6-(pentyloxycarbonyl)phenyl] ester
bis[2,4,5-trichloro-6-(pentyloxycarbonyl)phenyl] oxalate
bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate
30431-54-0
O0236
bis(3,4,6-trichloro-2-pentoxycarbonylphenyl) oxalate
A820371
bis(2,4,5-trichloro-6-carbopentoxyphenyl)oxalate
unii-44594f9xr2
ethanedioic acid, 1,2-bis(3,4,6-trichloro-2-((pentyloxy)carbonyl)phenyl) ester
bis(2,4,5-trichloro-6-carbopentoxyphenyl) oxalate
44594f9xr2 ,
einecs 250-195-3
ethanedioic acid, bis(3,4,6-trichloro-2-((pentyloxy)carbonyl)phenyl) ester
c26h24cl6o8
cppo
FT-0623115
ethanedioic acid, bis[3,4,6-trichloro-2-[(pentyloxy)carbonyl]phenyl] ester
SCHEMBL79416
DTXSID0067559
W-106942
mfcd00191674
pentyl 2,3,5-trichloro-6-[(2-oxo-2-{3,4,6-trichloro-2-[(pentyloxy)carbonyl]phenoxy}acetyl)oxy]benzoate
AS-73536
bis(3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl) oxalate
bis(2-carbopentyloxy-3,4,6-trichlorophenyl) oxalate
bis-(2,4,5-trichloro-6-(pentyloxycarbonyl)phenyl)oxalate
Q15410297
D70542
ethanedioic acid, 1,2-bis[3,4,6-trichloro-2-[(pentyloxy)carbonyl]phenyl] ester
bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl]oxalate
dipentyl o,o'-oxalyl-bis(3,5,6-trichlorosalicylate)
CS-0152132
bis(3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl)oxalate
bis(2,4,5-trichloro-6-carbopentyloxyphenyl)oxalate
oxalic acid, diester with pentyl 3,5,6-trichlorosalicylate
bis(6-carbopentoxy-2,4,5-trichlorophenyl)oxalate
bis(6-carbopentoxy-2,4,5-trichlorophenyl) oxalate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's1 (10.00)24.3611
2020's4 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
choline
[no description available]		1.9610cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
lactic acid
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed). 2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.		2.6102-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
hydrogen
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.. dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.		2.0310elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
haloperidol
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279). haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.		1.9810aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
acetonitrile
acetonitrile: RN given refers to unlabeled cpd. acetonitrile : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by a methyl group.		2.0410aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
xanthenes
Xanthenes: Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.		1.9610xanthene
1-methyl-4-phenylpyridinium
1-Methyl-4-phenylpyridinium: An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.. N-methyl-4-phenylpyridinium : A pyridinium ion that is N-methylpyridinium having a phenyl substituent at the 4-position.		1.9810pyridinium ionapoptosis inducer;
herbicide;
human xenobiotic metabolite;
neurotoxin
9,10-bis(phenylethynyl)anthracene
[no description available]		2.0710anthracenes;
arylacetylene;
benzenes		fluorochrome
peroxyoxalate
[no description available]		1.9610
n-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium
N-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium: a neurotoxic quaternary haloperidol metabolite in rat liver; structure in first source		1.9810
singlet oxygen
Singlet Oxygen: An excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.		2.3110chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
bis(2,4,6-trichlorophenyl)oxalate
bis(2,4,6-trichlorophenyl)oxalate: chemiluminescence reagent		2.3720
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy: structure given in first source		2.0310
aluminum
Aluminum: A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.		2.0410boron group element atom;
elemental aluminium;
metal atom
phytochlorin
phytochlorin: RN given refers to (2S-trans)-isomer; structure given in the first source		2.3110
oxalates
Oxalates: Derivatives of OXALIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are derived from the ethanedioic acid structure.		3.5280
doxo-emch
DOXO-EMCH: albumin-binding prodrug of doxorubicin		2.3110
ConditionIndicatedRelationship StrengthStudiesTrials
Acute Kidney Failure
[description not available]		02.610
Acute Kidney Injury
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.		02.610
Benign Neoplasms
[description not available]		02.610
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		02.610
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.2510
Innate Inflammatory Response
[description not available]		02.2510
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.		02.2510
Acute Liver Injury, Drug-Induced
[description not available]		01.9810
Chemical and Drug Induced Liver Injury
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.		01.9810